Concepedia

Thomas M. O’Dorisio

TM

262

Publications

16.9K

Citations

64

H-Index

1973

Active since

Affiliations

The Ohio State University(Current)

University of Iowa

Ohio State University Hospital

Thomas M. O’Dorisio is an author at The Ohio State University specializing in medicine, pharmacology, and pathology.

Top concepts

MedicinePharmacologyPathologyGastroenterologyPhysiologyEndocrinologyDiabetesOncologyHealthNeuroendocrine Tumors

Publications per year

1973–2023

262

Publications

262

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3K citations · Full text

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 648 citations · Full text

Octreotide Lar, Surgical Oncology, Pancreatic Cancer +15

Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

Al B. Benson, Jaffer A. Ajani, Robert B. Catalano et al. · Journal of Clinical Oncology · 2004 · 622 citations

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli et al. · PubMed · 2005 · 375 citations

Tumor Regression, Oncology, Engineering +15

<sup>90</sup>Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio et al. · Journal of Clinical Oncology · 2010 · 303 citations · Full text

Rows per page

1–5 of 262